Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Ariad
Pharma
Takeda's Iclusig wins first-line FDA nod to treat Ph+ALL
The FDA has approved Takeda's Iclusig for use plus chemotherapy for newly diagnosed, first-line patients with Philadelphia chromosome-positive ALL.
Kevin Dunleavy
Mar 19, 2024 3:22pm
Takeda to open U.S. HQ in Boston, shuttering Chicago site
Sep 12, 2018 11:22am
Former Ariad employees, spouse face insider trading charges
Jun 28, 2017 11:51am
New-look Takeda Oncology gears up for Roche ALK battle
Jun 5, 2017 9:51am
FiercePharmaAsia—Takeda, WuXi NextCODE, Dr. Reddy’s
May 5, 2017 9:51am
About that pharma M&A comeback? Keep on waiting
Apr 10, 2017 8:00am
